Inivata

Inivata, a global clinical cancer genomics company, is transforming personalized healthcare in oncology by utilizing the precision of circulating tumor (ctDNA) analysis. Inivata’s platform brings together Next-Generation sequencing (NGS) technology with proprietary algorithms and databases that guide genomic profiles to clinical outcomes. Using a simple blood test, ctDNA analysis is a new tool for oncologists to detect cancer, stratify patients, and assess individual response to treatment. Inivata recently completed a highly successful Series A fundraising of $45m to accelerate clinical studies and commercialize the company’s first products.
Inivata is a fast-paced, dynamic startup company with founders who are pioneers in the field of ctDNA analysis. We are a dedicated team with strong foundations and leadership and are all passionate about modernizing cancer care and treatment for patients. Inivata employees have both drive and determination to work successfully as individuals and as a team to revolutionize cancer care. As part of this role there will be international travel and collaboration between the US/UK offices that brings a global-community feel to Inivata as we tackle the universal disturbance of cancer together with our most advanced technology.